3STEED M E, RYBAK M J. Ceftaroline:a new cephalosporin with activity against resistant gram-positive pathogens [ J ]. Pharmacotherapy,2010,30(4) :375 -389.
4ZHANEL G G, SNJEZEK G, SCHWEIEER F. Ceftaroline: a novel broad-spectrum cephalosporin with activity against meti-cillin-resistant Staphylococcus aureus [J]. Drugs, 2009, 69 (7) :809 -831.
同被引文献58
1Wang Y, Serradell N, Rosa E, et al. Ceftaroline fosamil. Cephalospo- tiomtibiotic[J]. Drugs Fut, 2008, 33(4): 302-309.
2Goto J, Sakane K, Teraji T. Studies of(aminoaryl)aeetami- halosporin derivatives. Ill.Synthesis and structure-activity :i,~nships in the aminothiadiazole series[J]. J Antibiot, 1984, 37 557-571.
3. Sakane K, Groto J. 2-Substituted hydroxyimino-2-(5-ami-no-l,2,4-thiadiazol-3-yl)acetic acid or its salt and their intermedi- ates[P]. GB: 2094794, 1982-09-22.
4Fujiwara Y, Shundo T, Fujii T. Preparation of thiadiazoleacetate crys- tals as materials for cephalosporins[P]. JP: 4077477, 1992-03-01.
5Zu K Y, Seung 0 H, Hong Y J, et al.Novel cephalosporin compounds and processes for prepara-tion thereotlP].EP:0397511, 1990-11 - 14.
6Takeo K, Keizo T,Yasuhide T, et al. Thiadiazolylacetamide deriva- tives, process for the preparation thereof and their use[P].EP: 0248434, 1987-12-09.
7Kanai T, Takayanagi K, Tanaka Y. Preparation of 1,2,4-thiadiazol (alkoxyimino)acetic acids as intermediates for cephalosporins[P].dP: 62286979, 1987-12-12.
8Poon H, Chang M H, Fung H B. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus[J]. Clin Ther, 2012, 34(4): 745-765.
9McCaig L F, McDonald L C, Mandal S, et al. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care[J]. Emerg lnfect Dis, 2006, 12(11): 1715-1723.
10Talbot G H, Thye D, Das A, et al. Phase 2 study of ceftaroline versus standard therapy in treatment ofcomplicated skin and skin structure infections[J]. Antmicrob Agents Chemother, 2007, 51(10): 3612-3616.
